Cell and Gene Therapy Market Competitive Analysis With Growth Forecast Till 2025

Latest released, the research study on Global Cell and Gene Therapy Market Report Forecast 2021 - 2030, offers a detailed overview of the factors influencing the global business scope. Cell and Gene Therapy Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Cell and Gene Therapy. The study covers emerging player's data, including competitive landscape, sales, revenue and global market share of top manufacturers are: Biogen Inc.; Novartis AG; Gilead Sciences; Ionis Pharmaceuticals, Inc.; Alnylam Pharmaceuticals Inc.

The global cell and gene therapy market reached a value of nearly $4,390.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 25.5% since 2015. The market is expected to grow from $4,390.3 million in 2020 to $15,482.3 million in 2025 at a rate of 28.7%. The market is then expected to grow at a CAGR of 17.3% from 2025 and reach $34,317.9 million in 2030.

Click the link to Get Exclusive Sample Copy of the Cell and Gene Therapy Market:

https://www.marketinsightsreports.com/reports/08103166943/cell-and-gene-therapy-market-global-market-opportunities-and-strategies-to-2030-covid-19-growth-and-change-including-1-by-product-cell-therapy-gene-therapy-2-by-application-oncology-neurological-disorders-others-covering-biogen-inc-novartis-ag-gilead-sciences-ionis-pharmaceuticals-inc-alnylam-pharmaceuticals-inc/inquiry?mode=69

Covid-19 Impact and Recovery Analysis:

The global Cell and Gene Therapy market report also includes the impact of the Covid-19 pandemic. Moreover, it offers an exhaustive analysis of aspects that will encounter the development of the market pre & post Covid-19 pandemic.

Scope

Markets Covered: 1) By Product: Cell Therapy; Gene Therapy
2) By Application: Oncology; Neurological Disorders; Others

Market Overview:

The cell and gene therapy market is segmented by product into cell therapy, and gene therapy. The gene therapy market was the largest segment of the cell and gene therapy market segmented by product, accounting for 72.4% of the total in 2020. Going forward, the gene therapy segment is expected to be the fastest growing segment in the cell and gene therapy market segmented by product, at a CAGR of 30.8% during 2020-2025.

The cell and gene therapy market is also segmented by application into oncology, neurological disorders, and others. The oncology market was the largest segment of the cell and gene therapy market segmented by application, accounting for 64.6% of the total in 2020. Going forward, the neurological disorders segment is expected to be the fastest growing segment in the cell and gene therapy market segmented by application, at a CAGR of 30.7% during 2020-2025.

North America was the largest region in the global cell and gene therapy market, accounting for 49.8% of the total in 2020. It was followed by the Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the cell and gene therapy market will be the Middle East and South America where growth will be at CAGRs of 60.5% and 59.9% respectively. These will be followed by Asia Pacific and Eastern Europe, where the markets are expected to register CAGRs of 49.4% and 38.9% respectively.

The global cell and gene therapy market is highly concentrated, with a small number of large players. The top ten competitors in the market made up to 97.46% share of the total market in 2019.Major players in the market include Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals, Inc., and Alnylam Pharmaceuticals, Inc.

The top opportunities in the cell and gene therapy market segmented by product will arise in the gene therapy segment, which will gain $8,977.0 million of global annual sales by 2025. The top opportunities in the cell and gene therapy market segmented by application will arise in the oncology segment, which will gain $6,730.2 million of global annual sales by 2025. The cell and gene therapy market size will gain the most in the USA at $3,360.9 million.

Regional Analysis:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Browse full Cell and Gene Therapy market report description with TOC:

https://www.marketinsightsreports.com/reports/08103166943/cell-and-gene-therapy-market-global-market-opportunities-and-strategies-to-2030-covid-19-growth-and-change-including-1-by-product-cell-therapy-gene-therapy-2-by-application-oncology-neurological-disorders-others-covering-biogen-inc-novartis-ag-gilead-sciences-ionis-pharmaceuticals-inc-alnylam-pharmaceuticals-inc?mode=69

Key factors of this Report:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

The research includes historic data from 2015 to 2025 and forecasts until 2030 which makes the reports an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Buy Full Report @:

https://www.marketinsightsreports.com/report/purchase/08103166943?mode=su?mode=69

Customization of this Report: This report can be customized as per your needs for additional data up to 5 companies or countries or 40 analyst hours.

Please contact our sales professional (sales@marketinsightsreports.com ), we will ensure you obtain the report which works for your needs.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
Market Insights Reports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. Market Insights Reports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.